Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
OTLK
Stock Latest News
The Fly
Largest borrow rate increases among liquid names
1d ago
RDW
KYIV
Premium
The Fly
Largest borrow rate increases among liquid names
7d ago
RDW
BULL
Premium
Company Announcements
Outlook Therapeutics CCO Jeff Evanson Steps Down
13d ago
8K
OTLK
Premium
The Fly
Largest borrow rate increases among liquid names
14d ago
SU
LIT
Premium
Company Announcements
FDA Issues Complete Response Letter to Outlook Therapeutics
16d ago
8K
OTLK
Premium
The Fly
Outlook Therapeutics submits Type A meeting request to FDA
16d ago
OTLK
Premium
The Fly
Marvell downgraded, Dollar Tree upgraded: Wall Street’s top analyst calls
20d ago
AHL
SWX
Premium
Ratings
Hold Rating for Outlook Therapeutics Amid FDA Setbacks and Financial Challenges
20d ago
OTLK
Premium
The Fly
Outlook Therapeutics downgraded to Neutral yesterday at Guggenheim after CRL
20d ago
OTLK
Premium
The Fly
Outlook Therapeutics downgraded at H.C. Wainwright
20d ago
OTLK
Premium
The Fly
Outlook CRL ‘a significant setback,’ doesn’t mean end for Lytenava, says Chardan
21d ago
OTLK
Premium
The Fly
Outlook Therapeutics downgraded to Neutral from Buy at Guggenheim
21d ago
OTLK
Premium
The Fly
Outlook Therapeutics’ resubmission for wet AMD candidate rejected by FDA
21d ago
OTLK
Premium
Company Announcements
Navigating Trade Turbulence: Outlook Therapeutics’ Struggle with Global Trade Policies
1M ago
OTLK
Premium
Company Announcements
Outlook Therapeutics Reports Q3 2025 Earnings and Milestones
1M ago
OTLK
Premium
The Fly
Outlook Therapeutics reports Q3 adjusted EPS (44c) vs. (83c) last year
1M ago
OTLK
Premium
Pre-Earnings
OTLK Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
OTLK
Premium
Company Announcements
Outlook Therapeutics Appoints New CEO Robert Charles Jahr
3M ago
8K
OTLK
Premium
The Fly
Outlook Therapeutics appoints Bob Jahr as CEO
3M ago
OTLK
Premium
The Fly
Outlook Therapeutics announces SMC recommendation of LYTENAVA
3M ago
OTLK
Premium
Company Announcements
Outlook Therapeutics Launches LYTENAVA in Europe
4M ago
8K
OTLK
Premium
The Fly
Outlook Therapeutics announces commercial launch of LYTENAVA in Germany, UK
4M ago
OTLK
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
